UBS O'Connor’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,903
| Closed | -$249K | – | 307 |
|
|
2025
Q1 | $249K | Sell |
32,903
-23,192
| -41% | -$176K | 0.01% | 216 |
|
|
2024
Q4 | $683K | Buy |
56,095
+10,120
| +22% | +$123K | 0.02% | 252 |
|
|
2024
Q3 | $770K | Sell |
45,975
-16,000
| -26% | -$268K | 0.02% | 300 |
|
|
2024
Q2 | $1.08M | Buy |
61,975
+2,623
| +4% | +$45.7K | 0.03% | 284 |
|
|
2024
Q1 | $1.01M | Buy |
59,352
+5,000
| +9% | +$85.2K | 0.03% | 270 |
|
|
2023
Q4 | $554K | Sell |
54,352
-50,648
| -48% | -$516K | 0.02% | 330 |
|
|
2023
Q3 | $950K | Buy |
105,000
+20,000
| +24% | +$181K | 0.02% | 331 |
|
|
2023
Q2 | $915K | Buy |
+85,000
| New | +$915K | 0.02% | 388 |
|